Meeting
2018 Gastrointestinal Cancers Symposium
Phase II study of copanlisib (BAY 80-6946) in combination with gemcitabine and cisplatin in advanced cholangiocarcinoma.
Authors
Rutika Jitesh Mehta
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
Rutika Jitesh Mehta , Dae Won Kim , Heloisa P. Soares , Jongphil Kim , Richard D. Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Translational Research
Clinical Trial Registration Number
NCT02631590
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr TPS525)
DOI
10.1200/JCO.2018.36.4_suppl.TPS525
Abstract #
TPS525
Poster Bd #
Q1
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Phase II study of copanlisib in combination with gemcitabine and cisplatin in advanced cholangiocarcinoma.
First Author: Elaine Tan
Poster
2018 ASCO Annual Meeting
Liposomal irinotecan (nal-IRI) plus 5-fluorouracil (5-FU) and leucovorin (LV) or gemcitabine plus cisplatin in advanced cholangiocarcinoma: The AIO-NIFE-trial, an open label, randomized, multicenter phase II trial.
First Author: Thomas Jens Ettrich
Poster
2018 Gastrointestinal Cancers Symposium
A phase 2 study of s-1 plus leucovorin in patients with untreated advanced cholangiocarcinoma (CCA).
First Author: Suebpong Tanasanvimon
Poster
2014 Gastrointestinal Cancers Symposium
Next-generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA).
First Author: Rachna T. Shroff